Global Cell Cryopreservation Market to Reach USD 104.8 Billion by 2035, Driven by Rapid Growth in Cell-Based Therapies

The global Cell Cryopreservation Market is poised for extraordinary growth over the next decade, fueled by accelerating advancements in regenerative medicine, cell-based therapies, and biopharmaceutical research. According to the latest industry outlook, the market was valued at US$ 14.9 billion in 2024 and is projected to reach US$ 104.8 billion by 2035, expanding at a strong compound annual growth rate (CAGR) of 19.4% from 2025 to 2035.

Cell cryopreservation has become a cornerstone technology in modern life sciences, enabling long-term storage of living cells while maintaining their viability, structure, and biological function. The increasing reliance on stem cells, CAR-T therapies, gene therapies, and personalized medicine has significantly elevated demand for reliable and scalable cryopreservation solutions across research, clinical, and commercial settings.

Preview essential insights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86912

Market Overview

Cell cryopreservation refers to the preservation of cells, tissues, and other biological specimens at ultra-low temperatures to halt metabolic activity and prevent degradation. Through controlled freezing, vitrification, and optimized cryoprotectant formulations, cells can be stored for extended periods and revived when needed for research or therapeutic use.

The market encompasses cryoprotectant agents, equipment such as freezers and liquid nitrogen tanks, and consumables including cryogenic vials and tubes, along with associated services. Over recent years, the market has evolved rapidly, supported by automation, digital monitoring systems, and improved thawing protocols that enhance post-thaw cell recovery rates.

Key Market Growth Drivers

Rising Demand for Cell-Based Therapies
One of the foremost drivers of the cell cryopreservation market is the growing adoption of cell-based therapies for treating chronic diseases, cancer, genetic disorders, and degenerative conditions. Stem cell therapies, CAR-T cell therapies, and other advanced therapy medicinal products (ATMPs) rely heavily on effective cryopreservation to ensure cell viability throughout manufacturing, storage, transport, and clinical use.

The increasing number of cell-based clinical trials globally further underscores the importance of robust cryogenic storage systems. Regulatory engagement, such as workshops organized by the U.S. Food & Drug Administration (FDA) through its Center for Biologics Evaluation and Research (CBER), has also helped standardize cryopreservation practices and reduce development risks for therapy developers.

Expansion of Biobanking
The rapid proliferation of biobanks for research and clinical applications has emerged as another major growth catalyst. Biobanks store vast collections of cells, tissues, and genetic materials for drug discovery, disease research, and personalized medicine. As demand grows for large-scale, high-quality sample storage, investments in advanced cryogenic infrastructure and standardized preservation protocols are increasing globally.

International initiatives and guidance, including those from the World Health Organization (WHO), continue to emphasize the importance of biospecimen integrity and long-term storage reliability, further strengthening the role of cryopreservation technologies.

Analysis of Key Players and Competitive Landscape

The global cell cryopreservation market is moderately consolidated, with leading players focusing on product innovation, strategic collaborations, and portfolio expansion. Prominent companies include:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Sartorius AG
• BioLife Solutions Inc.
• PromoCell GmbH
• Lonza Group Ltd
• HiMedia Laboratories
• Creative Biolabs
• Corning Incorporated
• Pluristyx, Inc.
• Helmer Scientific Inc.
• Cardinal Health
• Takara Bio Inc.
• STEMCELL Technologies.
• GE HealthCare
• Other Prominent Players
These companies are profiled based on their business strategies, product portfolios, geographic presence, and recent developments.

Key Player Strategies

Market leaders are actively investing in advanced cryopreservation media, controlled-rate freezers, automation, and digital monitoring systems. Strategic partnerships with cell therapy developers and biobanks, along with geographic expansion into high-growth regions, remain key priorities. Many players are also aligning product development with evolving regulatory standards to ensure compliance and market readiness.

Recent Developments

• In February 2025, BioLife Solutions, Inc. expanded its product range to include advanced cryopreservation media and controlled-rate freezers. These additions respond to the ever-increasing demand for cell and gene therapies alongside the preservation and storage of biological materials.

• In September 2024, Colder Products Company developed Aseptic micro-connectors, compatible with freeze cassettes for processing in gene and cell therapies. This new design facilitates the junctions to be formed external to the biosafety cabinets enhancing ease of handling biological samples and mitigates wastage during storage and transport.

• In April 2024, Thermo Fisher Scientific introduced the Thermo ScientificTM TSXTM Core Series ULT freezers, designed to provide reliable performance and durability in a user-friendly solution.

• In April 2024, Pluristyx launched its proprietary cryopreservation medium solution, PluriFreeze. PluriFreeze is an innovative solution designed for supporting cell metabolism and easing pluripotent stem and the other energetically active cells to and from the frozen state for enhancing post-thaw viability and function.

Market Challenges and Opportunities

Despite its strong outlook, the cell cryopreservation market faces certain challenges. High capital costs associated with advanced freezing equipment, cryogenic storage facilities, and energy-intensive operations can limit adoption, particularly in emerging economies. Additionally, maintaining cell integrity during thawing and minimizing cryo-injury remain technical challenges.

However, these challenges also present significant opportunities. Continuous innovation in cryoprotectant formulations, controlled-rate freezing, vitrification techniques, and automation is improving efficiency and reducing operational risks. As technologies mature and economies of scale are realized, cost barriers are expected to ease, opening new growth avenues in developing regions.

Buy this Premium Research Report to explore detailed market trends - https://www.transparencymarketresearch.com/checkout.php?rep_id=86912<ype=S

Market Segmentation Insights

By Product
• Cryoprotectant Agents:
• Ethylene Glycol
• Dimethyl Sulfoxide
• Glycerol
• Others

Equipment
• Freezers
• Incubators
• Liquid Nitrogen Supply Tanks

Consumables
• Cryogenic vials
• Cryogenic tubes
• Cooler boxes/containers
• Others

By Application
• Stem Cells
• Reproductive Cells
• Bioproduction Cell Lines
• Primary Cells
• Others

By End-user
• Biopharmaceutical & Pharmaceutical Companies
• Academic and Research Institutes
• Biobanks
• IVF clinics
• Others

Regions Covered
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Investment Landscape and ROI Outlook

The cell cryopreservation market presents a highly attractive investment opportunity, supported by strong long-term demand fundamentals. Venture capital and private equity investments in cell therapy, regenerative medicine, and biobanking are driving parallel investments in cryogenic infrastructure. With a projected CAGR of 19.4%, the market offers compelling returns for investors focusing on innovative technologies and scalable solutions.

Why Buy This Report?

• Comprehensive analysis of market size, growth trends, and forecasts up to 2035
• Detailed segmentation by product, application, end user, and region
• In-depth competitive landscape and company profiles
• Insights into regulatory trends, technological advancements, and investment opportunities
• Strategic intelligence to support informed business and investment decisions

Frequently Asked Questions (FAQs)

1. How big was the global cell cryopreservation market in 2024?
The market was valued at US$ 14.9 billion in 2024.

2. How big will the global cell cryopreservation industry be in 2035?
It is projected to reach more than US$ 104.8 billion by 2035.

3. What are the key factors driving the market?
Rising demand for cell-based therapies and the expansion of biobanking are major growth drivers.

4. What will be the CAGR during the forecast period?
The market is expected to grow at a CAGR of 19.4% from 2025 to 2035.

5. Which region will dominate the market?
North America is expected to account for the largest market share during the forecast period.

Explore Latest Research Reports by Transparency Market Research:

Forensic Genomics Market: https://www.transparencymarketresearch.com/forensic-genomics-market.html

Multiomics Market: https://www.transparencymarketresearch.com/multiomics-market.html

Animal Model Market: https://www.transparencymarketresearch.com/animal-model-market.html

Fragment Based Drug Discovery Market: https://www.transparencymarketresearch.com/fragment-based-drug-discovery-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.